| Immune checkpoint inhibitor associated hepatotoxicity in primary liver cancer versus other cancers: a systematic review and meta‐analysis J Fu, WZ Li, NA McGrath, CW Lai, G Brar, YQ Xiang, C Xie Frontiers in oncology 11, 650292, 2021 | 28 | 2021 |
| Systemic treatment options for advanced biliary tract carcinoma C Xie, NA McGrath, C Monge Bonilla, J Fu Journal of Gastroenterology 55, 944-957, 2020 | 22 | 2020 |
| Targeting cancer stem cells in cholangiocarcinoma NA McGrath, J Fu, SZ Gu, C Xie International Journal of Oncology 57 (2), 397-408, 2020 | 20 | 2020 |
| Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus CM Bonilla, NA McGrath, J Fu, C Xie Hepatoma research 6, 2020 | 8 | 2020 |
| Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma J Fu, NA McGrath, J Lee, X Wang, G Brar, C Xie Hepatobiliary & Pancreatic Diseases International 21 (5), 485-492, 2022 | 4 | 2022 |
| TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells C Xie, NA McGrath Annals of Translational Medicine 8 (5), 2020 | 3 | 2020 |
